Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Synthesizing Diverse Lung Nodules Wherever Massively: 3D Multi-Conditional GAN-Based CT Image Augmentation for Object Detection
147
Zitationen
9
Autoren
2019
Jahr
Abstract
Accurate Computer-Assisted Diagnosis, relying on large-scale annotated pathological images, can alleviate the risk of overlooking the diagnosis. Unfortunately, in medical imaging, most available datasets are small/fragmented. To tackle this, as a Data Augmentation (DA) method, 3D conditional Generative Adversarial Networks (GANs) can synthesize desired realistic/diverse 3D images as additional training data. However, no 3D conditional GAN-based DA approach exists for general bounding box-based 3D object detection, while it can locate disease areas with physicians' minimum annotation cost, unlike rigorous 3D segmentation. Moreover, since lesions vary in position/size/attenuation, further GAN-based DA performance requires multiple conditions. Therefore, we propose 3D Multi-Conditional GAN (MCGAN) to generate realistic/diverse 32 × 32 × 32 nodules placed naturally on lung Computed Tomography images to boost sensitivity in 3D object detection. Our MCGAN adopts two discriminators for conditioning: the context discriminator learns to classify real vs synthetic nodule/surrounding pairs with noise box-centered surroundings; the nodule discriminator attempts to classify real vs synthetic nodules with size/attenuation conditions. The results show that 3D Convolutional Neural Network-based detection can achieve higher sensitivity under any nodule size/attenuation at fixed False Positive rates and overcome the medical data paucity with the MCGAN-generated realistic nodules-even expert physicians fail to distinguish them from the real ones in Visual Turing Test.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.830 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.481 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.894 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 10.010 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.416 Zit.